Shares of TTM Technologies vaulted 10.6% in pre-market trading to $134.00, capping a blistering 31.6% rally from $101.77 on July 29, as traders bet heavily that the company's Q2 2026 earnings would confirm an acceleration in its defense and data-center circuit board business. TTM Technologies Crosses $1 Billion in Quarterly Sales for the First Time — Can AI and Defense Spending Keep the Momentum Going?
Shares of TTM Technologies surged 10.6% to $134.00 in pre-market trading as investors digested a blowout Q2 that validated the bullish bets driving the stock up more than 31% in just over a week. The printed circuit board maker reported record non-GAAP earnings of $0.99 per share on revenue of $1.0 billion, topping Wall Street expectations of $0.92 and $962 million, respectively. The question now: at roughly 27 times the company's raised full-year earnings forecast, is the stock pricing in perfection?
• AI Data-Center Demand Is the Engine — and It Nearly Doubled
AI-related demand significantly supported Q2 performance, with Data Center and Networking comprising 40% of net sales and growing 91% year over year. That one segment effectively carried the company past the billion-dollar quarterly threshold. For shareholders, concentration in a single white-hot end market is a double-edged sword: spectacular when capital spending accelerates, vulnerable if hyperscalers pause orders.
• Profits Are Growing Even Faster Than Sales
Non-GAAP earnings per share of $0.99 rose 71% from a year earlier , far outpacing the 37% revenue jump. Gross margin improved to 21.9% from 20.9%, and operating margin rose to 13.8% from 11.1%. That widening gap between revenue growth and profit growth signals improving manufacturing efficiency — each additional dollar of sales is dropping more to the bottom line.
• Management Raised the Bar for the Rest of 2026
TTM now expects roughly $4.4 billion in full-year revenue and nearly $5 in non-GAAP EPS , up from a prior target of at least $4 billion. Q3 guidance calls for $1.10–$1.14 billion in sales and EPS of $1.21–$1.27 — implying further acceleration. Beyond 2026, management is targeting 15–20% organic revenue growth for both 2027 and 2028.
• Defense Backlog and European Deals Add a Second Growth Lever
Aerospace and Defense revenue grew 14%, backed by a $1.7 billion backlog and a book-to-bill ratio of 1.3 — meaning new orders outpace shipments. Two pending European acquisitions are expected to close in Q3, expanding TTM's reach in medical and defense markets. Combined with a new U.S. factory ramping in late 2026, these moves diversify revenue away from pure AI exposure — a cushion shareholders may appreciate if tech spending cools.
At $134, the stock trades at roughly 27× the ~$5 full-year EPS target. TTM has beaten consensus EPS estimates in each of the last four quarters , but the premium leaves little room for a stumble.